These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
159 related articles for article (PubMed ID: 16873432)
1. Overexpression of phosphatase of regenerating liver-3 in breast cancer: association with a poor clinical outcome. Wang L; Peng L; Dong B; Kong L; Meng L; Yan L; Xie Y; Shou C Ann Oncol; 2006 Oct; 17(10):1517-22. PubMed ID: 16873432 [TBL] [Abstract][Full Text] [Related]
2. Prognostic and metastatic value of phosphatase of regenerating liver-3 in invasive breast cancer. Hao RT; Zhang XH; Pan YF; Liu HG; Xiang YQ; Wan L; Wu XL J Cancer Res Clin Oncol; 2010 Sep; 136(9):1349-57. PubMed ID: 20140626 [TBL] [Abstract][Full Text] [Related]
4. Clinical importance of phosphatase of regenerating liver-3 expression in breast cancer. Ustaalioglu BB; Bilici A; Barisik NO; Aliustaoglu M; Vardar FA; Yilmaz BE; Seker M; Gumus M Clin Transl Oncol; 2012 Dec; 14(12):911-22. PubMed ID: 22855168 [TBL] [Abstract][Full Text] [Related]
5. Combined expression of metastasis related markers Naa10p, SNCG and PRL-3 and its prognostic value in breast cancer patients. Min L; Ma RL; Yuan H; Liu CY; Dong B; Zhang C; Zeng Y; Wang L; Guo JP; Qu LK; Shou CC Asian Pac J Cancer Prev; 2015; 16(7):2819-26. PubMed ID: 25854368 [TBL] [Abstract][Full Text] [Related]
6. Prognostic significance of high phosphatase of regenerating liver-3 expression in patients with gastric cancer who underwent curative gastrectomy. Bilici A; Ustaalioglu BB; Yavuzer D; Seker M; Mayadagli A; Gumus M Dig Dis Sci; 2012 Jun; 57(6):1568-75. PubMed ID: 22331511 [TBL] [Abstract][Full Text] [Related]
7. Expression of phosphatase of regenerating liver-3 (PRL-3) in endometrioid cancer and lymph nodes metastases. Guzińska-Ustymowicz K; Kiśluk J; Terlikowski SJ; Pryczynicz A; Niewiarowska K; Ustymowicz M; Hawryluk M; Południewski M; Kemona A Adv Med Sci; 2013; 58(2):221-6. PubMed ID: 23729584 [TBL] [Abstract][Full Text] [Related]
8. Prognostic value of PRL-3 overexpression in early stages of colonic cancer. Xing X; Peng L; Qu L; Ren T; Dong B; Su X; Shou C Histopathology; 2009 Feb; 54(3):309-18. PubMed ID: 19236507 [TBL] [Abstract][Full Text] [Related]
9. High PRL-3 expression in human gastric cancer is a marker of metastasis and grades of malignancies: an in situ hybridization study. Miskad UA; Semba S; Kato H; Matsukawa Y; Kodama Y; Mizuuchi E; Maeda N; Yanagihara K; Yokozaki H Virchows Arch; 2007 Mar; 450(3):303-10. PubMed ID: 17235563 [TBL] [Abstract][Full Text] [Related]
10. Mesenchymal and Phosphatase of Regenerating Liver-3 Status in Circulating Tumor Cells May Serve as a Crucial Prognostic Marker for Assessing Relapse or Metastasis in Postoperative Patients With Colorectal Cancer. Su P; Lai W; Liu L; Zeng Y; Xu H; Lan Q; Chu Z; Chu Z Clin Transl Gastroenterol; 2020 Dec; 11(12):e00265. PubMed ID: 33512811 [TBL] [Abstract][Full Text] [Related]
11. Expression and prognostic impact of the protein tyrosine phosphatases PRL-1, PRL-2, and PRL-3 in breast cancer. Radke I; Götte M; Kersting C; Mattsson B; Kiesel L; Wülfing P Br J Cancer; 2006 Aug; 95(3):347-54. PubMed ID: 16832410 [TBL] [Abstract][Full Text] [Related]
12. Expression and clinical role of protein of regenerating liver (PRL) phosphatases in ovarian carcinoma. Reich R; Hadar S; Davidson B Int J Mol Sci; 2011 Feb; 12(2):1133-45. PubMed ID: 21541048 [TBL] [Abstract][Full Text] [Related]
13. The association of the expression level of protein tyrosine phosphatase PRL-3 protein with liver metastasis and prognosis of patients with colorectal cancer. Peng L; Ning J; Meng L; Shou C J Cancer Res Clin Oncol; 2004 Sep; 130(9):521-6. PubMed ID: 15133662 [TBL] [Abstract][Full Text] [Related]
14. Over-expression of phosphatase of regenerating liver-3 correlates with tumor progression and poor prognosis in nasopharyngeal carcinoma. Zhou J; Wang S; Lu J; Li J; Ding Y Int J Cancer; 2009 Apr; 124(8):1879-86. PubMed ID: 19101992 [TBL] [Abstract][Full Text] [Related]
15. Expression of phosphatase regenerating liver 3 is an independent prognostic indicator for gastric cancer. Dai N; Lu AP; Shou CC; Li JY World J Gastroenterol; 2009 Mar; 15(12):1499-505. PubMed ID: 19322925 [TBL] [Abstract][Full Text] [Related]
16. Enhanced prediction of breast cancer prognosis by evaluating expression of p53 and prostate-specific antigen in combination. Yu H; Levesque MA; Clark GM; Diamandis EP Br J Cancer; 1999 Oct; 81(3):490-5. PubMed ID: 10507775 [TBL] [Abstract][Full Text] [Related]
17. A retrospective cohort study of clinical value of PRL-3 in stage III human colorectal cancer. Liu C; Zhong W; Xia L; Fang C; Liu H; Liu X Medicine (Baltimore); 2021 Apr; 100(17):e25658. PubMed ID: 33907129 [TBL] [Abstract][Full Text] [Related]
18. Association of tyrosine PRL-3 phosphatase protein expression with peritoneal metastasis of gastric carcinoma and prognosis. Li ZR; Wang Z; Zhu BH; He YL; Peng JS; Cai SR; Ma JP; Zhan WH Surg Today; 2007; 37(8):646-51. PubMed ID: 17643206 [TBL] [Abstract][Full Text] [Related]
19. PRL-3 is a potential glioblastoma prognostic marker and promotes glioblastoma progression by enhancing MMP7 through the ERK and JNK pathways. Mu N; Gu J; Liu N; Xue X; Shu Z; Zhang K; Huang T; Chu C; Zhang W; Gong L; Zhao H; Jia B; Gao D; Shang L; Zhang W; Guo Q Theranostics; 2018; 8(6):1527-1539. PubMed ID: 29556339 [No Abstract] [Full Text] [Related]
20. Phosphatase of regenerating liver-3 (PRL-3) is associated with metastasis and poor prognosis in gastric carcinoma. Xing X; Lian S; Hu Y; Li Z; Zhang L; Wen X; Du H; Jia Y; Zheng Z; Meng L; Shou C; Ji J J Transl Med; 2013 Dec; 11():309. PubMed ID: 24330843 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]